Related references
Note: Only part of the references are listed.A Left-Handed Solution to Peptide Inhibition of the p53-MDM2 Interaction
Min Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Systematic Mutational Analysis of Peptide Inhibition of the p53-MDM2/MDMX Interactions
Chong Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Apamin as a Template for Structure-Based Rational Design of Potent Peptide Activators of p53
Chong Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Total chemical synthesis of proteins
Stephen B. H. Kent
CHEMICAL SOCIETY REVIEWS (2009)
Direct inhibition of the NOTCH transcription factor complex
Raymond E. Moellering et al.
NATURE (2009)
Advances in the genetics of glioblastoma: are we reaching critical mass?
Benjamin Purow et al.
NATURE REVIEWS NEUROLOGY (2009)
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Marzena Pazgiera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
The Penetratin Sequence in the Anticancer PNC-28 Peptide Causes Tumor Cell Necrosis Rather Than Apoptosis of Human Pancreatic Cancer Cells
Wilbur B. Bowne et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Reduction of Alzheimer's Disease Amyloid Plaque Load in Transgenic Mice by D3, a D-Enantiomeric Peptide Identified by Mirror Image Phage Display
Thomas van Groen et al.
CHEMMEDCHEM (2008)
Turning a scorpion toxin into an antitumor miniprotein
Chong Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Potent D-peptide inhibitors of HIV-1 entry
Brett D. Welch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
Federico Bernal et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
MDMX: from bench to bedside
Jean-Christophe W. Marine et al.
JOURNAL OF CELL SCIENCE (2007)
Targeting protein-protein interactions: Lessons from p53/MDM2
Justin K. Murray et al.
BIOPOLYMERS (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
Franck Toledo et al.
NATURE REVIEWS CANCER (2006)
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer
JS Wadia et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Tat peptide-mediated cellular delivery:: back to basics
H Brooks et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Transcellular protein transduction using the Tat protein of HIV-1
A Fittipaldi et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
LD Walensky et al.
SCIENCE (2004)
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
LK Linares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
P de Graaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
MDM2 promotes ubiquitination and degradation of MDMX
Y Pan et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site
TN Do et al.
ONCOGENE (2003)
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells
M Kanovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides
CE Schafmeister et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
